Exagen GAAP EPS of -$0.20 in-line, revenue of $15.5M beats by $0.95M
Source: SeekingAlpha
2025-05-05 08:03:01 ET
More on Exagen
- Exagen: Buy An Undervalued Diagnostics Developer That Is On The Path To Profitability
- Exagen Inc. (XGN) Q4 2024 Earnings Call Transcript
- Exagen announces senior secured credit facility
- Seeking Alpha’s Quant Rating on Exagen
- Historical earnings data for Exagen
Read the full article on Seeking Alpha
For further details see:
Exagen GAAP EPS of -$0.20 in-line, revenue of $15.5M beats by $0.95M
Exagen Inc.
NASDAQ: XGN
XGN Trading
-0.49% G/L:
$3.065 Last:
44,592 Volume:
$3.16 Open:
XGN Latest News
February 24, 2026 09:00:00 am
Exagen Inc. to Announce Fourth Quarter and Full Year 2025 Financial Results on March 10, 2026
XGN Stock Data
$80,000,739
13,869,817
3.15%
15
N/A
Medical Diagnostics & Screening
Healthcare
US
Vista
